[Skip to Content]
[Skip to Content Landing]
Article
December 1992

Diode Laser Photocoagulation for Retinopathy of PrematurityPreliminary Results

Author Affiliations

From the Retina Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pa. The authors have no commercial or proprietary interest in IRIS Medical Inc, Mountain View, Calif, or the OcuLight SLx diode laser. The authors have not received any payment from IRIS Medical Inc as consultants, reviewers, or evaluators.

Arch Ophthalmol. 1992;110(12):1714-1716. doi:10.1001/archopht.1992.01080240054029
Abstract

• In a prospective, randomized clinical trial comparing transscleral cryotherapy with laser photocoagulation in the treatment of "threshold" stage 3+ retinopathy of prematurity, 32 infants were treated with diode laser photocoagulation in one eye. Twenty-eight infants have been followed up for at least 3 months, and seven have been followed up for at least 1 year. Twenty-five of 28 eyes treated with diode laser photocoagulation and followed up for at least 3 months have undergone regression. Of 24 fellow eyes treated with cryotherapy and followed up for at least 3 months, 20 have undergone regression. All seven eyes treated with diode laser photocoagulation and followed up for at least 1 year have undergone regression. Of seven fellow eyes treated with cryotherapy and followed up for at least 1 year, all have undergone regression. Our results suggest that diode laser photocoagulation is as effective as cryotherapy in the treatment of retinopathy of prematurity.

×